Viewing StudyNCT05837052



Ignite Creation Date: 2024-05-06 @ 6:56 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05837052
Status: RECRUITING
Last Update Posted: 2023-07-17
First Post: 2023-04-17

Brief Title: A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC
Sponsor: Zhejiang University
Organization: Zhejiang University

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-05-15
Start Date Type: ACTUAL
Primary Completion Date: 2025-06-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12-30
Completion Date Type: ESTIMATED
First Submit Date: 2023-04-17
First Submit QC Date: April 27 2023
Study First Post Date: 2023-05-01
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-14
Last Update Post Date: 2023-07-17
Last Update Post Date Type: ACTUAL